Results 121 to 130 of about 338,921 (264)
ERS Congress 2025: highlights from the Pulmonary Vascular Diseases Assembly. [PDF]
Budhram B +18 more
europepmc +1 more source
A glutathione and ultrasound dual‐responsive cerasome achieves sequential co‐delivery of gemcitabine and BMS1166 in tumors. Chemotherapy priming followed by on‐demand PD‐L1 blockade synergistically amplifies anti‐tumor immunity, inhibiting primary tumor growth, distant metastasis and inducing durable immune memory.
Suhui Sun +9 more
wiley +1 more source
Effect of sildenafil on resting and exercise haemodynamics in hypoxia in patients with pulmonary vascular diseases: data from a randomised controlled trial. [PDF]
Lichtblau M +9 more
europepmc +1 more source
High‐throughput Differential Dynamic Microscopy measures frequency‐resolved mechanical fingerprints from 3 to 10 μL$\umu{\rm L}$ mucus samples using only a few minutes of operator attention per sample. This automated analysis enables scalable mucus phenotyping for translational research by distinguishing mechanical heterogeneity among donors, disease ...
Feng Ling +18 more
wiley +1 more source
ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly. [PDF]
Foris V +7 more
europepmc +1 more source
Endowing Flexibility of Alveolar Type II Cells to Recapitulate Development From Lung Bud to Alveoli
Adult human alveolar type 2 cells are chemically reprogrammed into expandable alveolar progenitor‐like cells that acquire bud tip‐like features during expansion and form organoids that mature into alveolar‐like structures. These organoids model influenza A virus infection and innate immune responses in vitro, while transplanted cells engraft ...
Hongqian Ma +18 more
wiley +1 more source
Alterations in Mitochondrial Function in Pulmonary Vascular Diseases. [PDF]
Farha S +25 more
europepmc +1 more source
Sepsis‑induced pediatric acute respiratory distress syndrome suppresses FOXF1 in lung endothelial cells which causes life‐threatening lung damage. To counter this, researchers developed nanoparticles that specifically target these cells and deliver FOXF1 mRNA.
Zicheng Deng +14 more
wiley +1 more source
Editorial: Immunity and pulmonary vascular diseases: challenges, advances and future perspectives. [PDF]
Jin Q, Zhou D, Liu Z, Kosanovic D.
europepmc +1 more source
Updates in pulmonary hypertension and other pulmonary vascular diseases. [PDF]
Bernardo RJ, Bokan A, Ramjug S.
europepmc +1 more source

